158 related articles for article (PubMed ID: 33348346)
21. Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: a review of the literature.
Ito MK
Atherosclerosis; 2015 Oct; 242(2):647-56. PubMed ID: 26296750
[TBL] [Abstract][Full Text] [Related]
22. Fish Oil Derivatives in Hypertriglyceridemia: Mechanism and Cardiovascular Prevention: What Do Studies Say?
Erbay MI; Gamarra Valverde NN; Patel P; Ozkan HS; Wilson A; Banerjee S; Babazade A; Londono V; Sood A; Gupta R
Curr Probl Cardiol; 2024 Jan; 49(1 Pt B):102066. PubMed ID: 37657524
[TBL] [Abstract][Full Text] [Related]
23. Are dietary fish oil supplements appropriate for dyslipidemia management? A review of the evidence.
Sherratt SCR; Lero M; Mason RP
Curr Opin Lipidol; 2020 Apr; 31(2):94-100. PubMed ID: 32022752
[TBL] [Abstract][Full Text] [Related]
24. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
McKenney JM; Sica D
Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
[TBL] [Abstract][Full Text] [Related]
25. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK;
Circulation; 2019 Sep; 140(12):e673-e691. PubMed ID: 31422671
[TBL] [Abstract][Full Text] [Related]
26. National Lipid Association Scientific Statement on the use of icosapent ethyl in statin-treated patients with elevated triglycerides and high or very-high ASCVD risk.
Orringer CE; Jacobson TA; Maki KC
J Clin Lipidol; 2019; 13(6):860-872. PubMed ID: 31787586
[TBL] [Abstract][Full Text] [Related]
27. Demystifying triglycerides: a practical approach for the clinician.
Dunbar RL; Rader DJ
Cleve Clin J Med; 2005 Aug; 72(8):661-6, 670-2, 674-5 passim. PubMed ID: 16122052
[TBL] [Abstract][Full Text] [Related]
28. Addition of omega-3 carboxylic acids to statin therapy in patients with persistent hypertriglyceridemia.
Davidson MH; Phillips AK; Kling D; Maki KC
Expert Rev Cardiovasc Ther; 2014 Sep; 12(9):1045-54. PubMed ID: 25089906
[TBL] [Abstract][Full Text] [Related]
29. Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia.
Wohl DA; Tien HC; Busby M; Cunningham C; Macintosh B; Napravnik S; Danan E; Donovan K; Hossenipour M; Simpson RJ
Clin Infect Dis; 2005 Nov; 41(10):1498-504. PubMed ID: 16231263
[TBL] [Abstract][Full Text] [Related]
30. Impact of omega-3 fatty acid oral therapy on healing of chronic venous leg ulcers in older adults: Study protocol for a randomized controlled single-center trial.
McDaniel JC; Rausch J; Tan A
Trials; 2020 Jan; 21(1):93. PubMed ID: 31948466
[TBL] [Abstract][Full Text] [Related]
31. Hypertriglyceridemia and omega-3 fatty acids: Their often overlooked role in cardiovascular disease prevention.
Arca M; Borghi C; Pontremoli R; De Ferrari GM; Colivicchi F; Desideri G; Temporelli PL
Nutr Metab Cardiovasc Dis; 2018 Mar; 28(3):197-205. PubMed ID: 29397253
[TBL] [Abstract][Full Text] [Related]
32. [High-dose Omega-3 for cardiovascular prevention, a bad idea?].
Berger C; Gencer B; Nanchen D
Rev Med Suisse; 2022 Mar; 18(772):434-437. PubMed ID: 35266343
[TBL] [Abstract][Full Text] [Related]
33. Omega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemia.
Benes LB; Bassi NS; Davidson MH
Vasc Health Risk Manag; 2016; 12():481-490. PubMed ID: 28003756
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and Safety of Adding Omega-3 Fatty Acids in Statin-treated Patients with Residual Hypertriglyceridemia: ROMANTIC (Rosuvastatin-OMAcor iN residual hyperTrIglyCeridemia), a Randomized, Double-blind, and Placebo-controlled Trial.
Kim CH; Han KA; Yu J; Lee SH; Jeon HK; Kim SH; Kim SY; Han KH; Won K; Kim DB; Lee KJ; Min K; Byun DW; Lim SW; Ahn CW; Kim S; Hong YJ; Sung J; Hur SH; Hong SJ; Lim HS; Park IB; Kim IJ; Lee H; Kim HS
Clin Ther; 2018 Jan; 40(1):83-94. PubMed ID: 29223557
[TBL] [Abstract][Full Text] [Related]
35. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
Nogueira MA; Oliveira CP; Ferreira Alves VA; Stefano JT; Rodrigues LS; Torrinhas RS; Cogliati B; Barbeiro H; Carrilho FJ; Waitzberg DL
Clin Nutr; 2016 Jun; 35(3):578-86. PubMed ID: 26047766
[TBL] [Abstract][Full Text] [Related]
36. Bridging the gap in treatment options for patients with hypertriglyceridemia.
Underberg JA; Hays R
J Fam Pract; 2007 Dec; 56(12 Suppl New):S24-31. PubMed ID: 18664339
[TBL] [Abstract][Full Text] [Related]
37. Comparative analysis of the efficacy of omega-3 fatty acids for hypertriglyceridaemia management in Korea.
Kim HS; Kim H; Jeong YJ; Yang SJ; Baik SJ; Lee H; Lee SH; Cho JH; Choi IY; Yim HW; Yoon KH
J Clin Pharm Ther; 2016 Oct; 41(5):508-14. PubMed ID: 27426000
[TBL] [Abstract][Full Text] [Related]
38. Triglycerides and ASCVD Risk Reduction: Recent Insights and Future Directions.
Hussain A; Ballantyne CM; Saeed A; Virani SS
Curr Atheroscler Rep; 2020 Jun; 22(7):25. PubMed ID: 32494924
[TBL] [Abstract][Full Text] [Related]
39. Have the heart for fish oil?
Johns Hopkins Med Lett Health After 50; 2008 Sep; 20(7):1-2. PubMed ID: 18822526
[No Abstract] [Full Text] [Related]
40. Fish oil and inflammatory disease: is asthma the next target for n-3 fatty acid supplements?
Stephensen CB
Nutr Rev; 2004 Dec; 62(12):486-9. PubMed ID: 15648824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
